医学
溶栓
随机对照试验
灌注扫描
内科学
冲程(发动机)
灌注
子群分析
心脏病学
荟萃分析
外科
放射科
临床试验
缺血性中风
临床终点
治疗窗口
计算机断层摄影术
脑灌注压
阶段(地层学)
作者
Marcello Naccarato,E. Ricci,Emanuele Vincis,Magda Quagliotto,Michele Malesani,Gianpiero Farina,Sofia Elettra Maurig,Paola Caruso,Giovanni Furlanis,Paolo Manganotti
标识
DOI:10.1016/j.jstrokecerebrovasdis.2026.108717
摘要
PURPOSE: Recent randomized controlled trials (RCTs) have provided new evidence regarding the efficacy and safety of intravenous thrombolysis (IVT) in patients with acute ischemic stroke (AIS) presenting within the extended time window (ETW). We performed a systematic review and meta-analysis to evaluate the efficacy and safety of IVT, in patients treated within the ETW and selected with perfusion imaging criteria, predominantly computed tomography perfusion (CTP). METHODS: A systematic review and meta-analysis, registered in PROSPERO, was conducted including all available RCTs comparing IVT with best medical treatment (BMT) in patients with AIS within the ETW, selected using advanced perfusion imaging criteria. The predefined efficacy outcomes were excellent functional outcome and good functional outcome at 3 months. The safety endpoints included symptomatic intracranial hemorrhage (sICH) and all-cause mortality at 90 days. RESULTS: Six RCTs, including 1182 patients treated with IVT and 1176 patients receiving BMT, were included. IVT was associated with a higher likelihood of achieving excellent and good functional outcomes at 3 months. Exploratory subgroup analyses by treatment timing suggested consistent findings up to 24 hours. No significant difference in 90-day mortality was observed between groups, whereas IVT was associated with an increased risk of sICH. CONCLUSION: Treatment with IVT in the ETW (4.5-24 h) in patients selected using advanced perfusion imaging, predominantly CTP, may be associated with improved functional outcomes in patients with AIS. Although IVT was associated with an increased risk of sICH, no significant increase in 90-day mortality was observed. PROSPERO REGISTRATION: CRD420261304314.
科研通智能强力驱动
Strongly Powered by AbleSci AI